PMG
ELV icon

ProVise Management Group’s Elevance Health ELV Stock Holding History

ProVise Management Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.66M Buy
26,180
+1,176
+5% +$387K 0.55% 50
2025
Q4 		$8.77M Buy
25,004
+1,938
+8% +$655K 0.62% 48
2025
Q3 		$7.45M Sell
23,066
-458
-2% -$142K 0.55% 50
2025
Q2 		$9.15M Buy
23,524
+3,277
+16% +$1.32M 0.72% 46
2025
Q1 		$8.81M Buy
20,247
+3,104
+18% +$1.25M 0.75% 46
2024
Q4 		$6.32M Sell
17,143
-4,665
-21% -$1.95M 0.54% 52
2024
Q3 		$11.3M Buy
21,808
+606
+3% +$324K 0.9% 32
2024
Q2 		$11.5M Buy
21,202
+433
+2% +$229K 0.98% 31
2024
Q1 		$10.8M Buy
20,769
+1,805
+10% +$898K 0.93% 34
2023
Q4 		$8.94M Buy
18,964
+2,195
+13% +$1.01M 0.76% 39
2023
Q3 		$7.3M Buy
16,769
+12,913
+335% +$5.86M 0.68% 44
2023
Q2 		$1.71M Buy
3,856
+22
+0.6% +$10.1K 0.16% 136
2023
Q1 		$1.76M Sell
3,834
-450
-11% -$214K 0.17% 124
2022
Q4 		$2.2M Sell
4,284
-1,692
-28% -$859K 0.22% 113
2022
Q3 		$2.71M Sell
5,976
-640
-10% -$306K 0.3% 92
2022
Q2 		$3.19M Sell
6,616
-853
-11% -$422K 0.34% 86
2022
Q1 		$3.67M Sell
7,469
-392
-5% -$179K 0.35% 83
2021
Q4 		$3.64M Sell
7,861
-55
-0.7% -$23.1K 0.33% 84
2021
Q3 		$2.95M Sell
7,916
-80
-1% -$30.4K 0.29% 97
2021
Q2 		$3.05M Sell
7,996
-107
-1% -$40.9K 0.31% 89
2021
Q1 		$2.91M Buy
8,103
+1,023
+14% +$329K 0.31% 96
2020
Q4 		$2.27M Buy
7,080
+668
+10% +$205K 0.26% 100
2020
Q3 		$1.72M Buy
6,412
+3,927
+158% +$1.06M 0.23% 107
2020
Q2 		$654K Buy
2,485
+206
+9% +$55K 0.09% 163
2020
Q1 		$517K Buy
2,279
+330
+17% +$89.9K 0.09% 169
2019
Q4 		$589K Buy
1,949
+60
+3% +$16.5K 0.07% 187
2019
Q3 		$454K Buy
1,889
+115
+6% +$31.5K 0.06% 203
2019
Q2 		$501K Buy
+1,774
New +$485K 0.07% 203
2018
Q3 		– Sell
-20
Closed -$4.76K – 328
2018
Q2 		$4.76K Buy
+20
New +$4.63K 0.36% 68

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

ProVise Management Group's ELV Position: Q1 2026 in Review

ProVise Management Group increased its Elevance Health (ELV) stake by 4.7% in Q1 2026, buying an estimated $387K and bringing the position to 26,180 shares worth $7.66M. The position accounts for 0.55% of the portfolio, ranked #50.

ProVise Management Group first reported a position in ELV in Q2 2018 and has held it in 29 quarters since. The position peaked at $11.5M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • ProVise Management Group held 26,180 shares of Elevance Health worth $7.66M as of Q1 2026.
  • ProVise Management Group bought 1,176 Elevance Health shares in Q1 2026, an estimated $387K.
  • Elevance Health made up 0.55% of ProVise Management Group's portfolio in Q1 2026, its #50 holding.
  • ProVise Management Group first reported a position in Elevance Health in Q2 2018 and has held it in 29 quarters since.
  • ProVise Management Group's Elevance Health position peaked at $11.5M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on ProVise Management Group's 13F filing for Q1 2026, filed 7 May 2026.